Ohio State University B-Vaxx Report, page-27

I am not sure what does your piece of paragraph meant, again cut and paste from some document does not mean anything, google and you will get hundreds of them and different interpretation, I am not sure what’s your interest here, I hold I have interest, you don’t hold and I am pretty sure your not some messiahs who is out here to warn and safeguard others investment, now about this stock this is just phase 1 dude , that’s why FDA has phase 2 and extended phase 2’s for getting reaction from larger sample group with different permutation and combination ,if a drug stop metasising your tumor that’s a first and big win, that means you just localised it, do you even imagine ,now it’s under control, controlling a problem opens up lot of option , my fil passed away with lung cancer, his problem was compounded as his tumor has metasised and doctors did not have enough time to control the spread, different organs react different when tumor spreads, you get pneumonia at first when it’s in lungs, when it spreads to stomach causes uncontrolled dirrrhea, buy the time docs control the symptoms patient would die due to this , and if docs could isolate these problems imagine the overall prognosis and that too without additional complications caused by drugs it self, chemo causes immune system breakdown , T cell immune vaccine causes heart wa ll complications, do this research, not just some cut and paste from FDA site and by the way those guidelines are written by docs and lawyers ( more lawyers) who write them just to keep the guessing game so it can be turned and twisted, the reason why imugene went for early FDA meeting